Foghorn Therapeutics Inc.
World Rank (Jan-05-2024)
16,628
Market Cap (Jan-05-2024)
0.256 Billion USD
World Rank (Jul-30-2023)
14,496
Market Cap (Jul-30-2023)
0.378 Billion USD
World Rank (Dec-25-2022)
17,091
Market Cap (Dec-25-2022)
0.238 Billion USD
World Rank (Jan-07-2022)
11,175
Market Cap (Jan-07-2022)
0.74 Billion USD
Annual Revenue in USD
1 Million USD
Annual Net Income in USD
-101 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Foghorn Therapeutics Inc. is Developing Therapies designed to modulate the chromatin regulatory system company. The company estimated annual revenue is currently 17.8 million USD per year and 85 employees as on 2020. The headquarters is in USA.
Company Website